ALT R&D Expenses
Altimmune Inc · R&D Expenses
ALT R&D Expenses
Latest reported$18.66Mperiod ending
ALT Quarterly R&D Expenses ($0.00 → $18.66M)
Quarterly R&D Expenses
High-resolution chart · PNG
ALT r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 18,655,000 | |
| 16,169,000 | |
| 18,409,000 | |
| 14,960,000 | |
| 17,236,000 | |
| 15,827,000 | |
| 19,781,000 | |
| 19,803,000 | |
| 21,155,000 | |
| 21,487,000 | |
| 16,909,000 | |
| 18,388,000 | |
| 13,253,000 | |
| 17,249,000 | |
| 19,179,000 | |
| 20,262,000 | |
| 15,993,000 | |
| 15,104,000 | |
| 20,185,000 | |
| 29,206,000 | |
| 13,272,000 | |
| 11,878,000 | |
| 8,950,572 | |
| 17,041,975 | |
| 16,594,250 | |
| 7,187,531 | |
| 3,873,089 | |
| 8,729,697 | |
| 2,945,096 | |
| 3,217,671 | |
| 3,064,694 | |
| 4,728,726 | |
| 4,918,961 | |
| 5,746,971 | |
| 4,459,926 | |
| 5,905,552 | |
| 5,254,729 | |
| 725,797 | |
| 1,427,030 | |
| 1,236,692 | |
| 1,143,182 | |
| 1,029,131 | |
| 1,171,493 | |
| 1,125,865 | |
| 1,222,527 | |
| 1,613,627 | |
| 1,791,212 | |
| 1,728,929 | |
| 2,372,687 | |
| 3,427,000 | |
| 4,097,739 | |
| 2,556,383 | |
| 3,402,545 | |
| 5,233,475 | |
| 4,746,995 | |
| 5,138,622 | |
| 4,918,655 | |
| 4,705,357 | |
| 4,531,150 | |
| 4,884,231 | |
| 5,984,098 | |
| 5,820,374 | |
| 3,810,636 | |
| 6,172,147 | |
| 5,940,360 | |
| 4,952,393 | |
| 7,450,009 | |
| 7,609,794 | |
| 9,464,629 | |
| 5,695,326 | |
| 5,336,995 | |
| 9,414,093 | |
| 11,184,288 | |
| 5,877,055 | |
| 5,825,378 | |
| 3,647,329 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |